AustralieFrV1, Istex, Curation, bibRecord, 002B20

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

Identifieur interne : 002B20 ( Istex/Curation ); précédent : 002B19; suivant : 002B21

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

Auteurs : Robert A. Upton [États-Unis] ; Jean-Francois Thiercelin [France] ; Theodor W. Guentert [Suisse] ; Sylvia M. Wallace [Canada] ; J. Robert Powell [États-Unis] ; Lloyd Sansom [Australie] ; Sidney Riegelman [États-Unis]

Source :

Journal of Pharmacokinetics and Biopharmaceutics [ 0090-466X ] ; 1982-04-01.

RBID : ISTEX:E5715019E678DCA7297BE8A6FC0D7FB05F87868B

English descriptors

Abstract

Abstract: After administering a single 300 mg dose of theophylline in oral solution to 12 healthy adults, the dose-normalized area under the plasma concentration-time curve was 97.2±20.1 % (mean±SD) of that after giving a 500 mg dose and statistically indistinguishable. Similarly, these areas multiplied by the individual's terminal disposition rate constant (β) were statistically indistinguishable between 300 and 500mg doses (99.1±10.3%), giving no evidence of dose-dependence for theophylline kinetics at the levels below 15 μg/ml observed in these individuals. After an intravenous dose, a shortlived distribution phase (t1/2α) is sometimes seen. An a phase, however, is hardly discernible in over 250 profiles arising from oral doses administered during five single dose bioavailability studies. Almost all such profiles appear to follow single-compartment model predictions. With precautions to avoid a potential a phase, a terminal log-linear slope can be fitted by least squares analysis with a relative standard error in the slope determination almost always less than 6%. Covariance analysis confirms statistically that 39 of the 60 participating individuals varied in their β on the different occasions each was required to take a dose during the course of a crossover bioavailability trial. In one study, even though each individual was observed on only two occasions, 9 out of 12 showed statistically identifiable variation in β. Fluctuations in β of 60% can be seen. Changes of 30% or greater are common and can occur within 3 or 4 days. Thus real, large, and potentially frequent changes in β of theophylline have been identified in a majority of normal subjects. These changes do not appear to be confined to either sex, to smokers or nonsmokers, or to heavier or lighter individuals. No chronological pattern has, as yet, been recognized in the intraindividual variability in β.

Url:

https://api.istex.fr/document/E5715019E678DCA7297BE8A6FC0D7FB05F87868B/fulltext/pdf

DOI: 10.1007/BF01062330

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B20

Links to Exploration step

ISTEX:E5715019E678DCA7297BE8A6FC0D7FB05F87868B

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults</title>
<author><name sortKey="Upton, Robert A" sort="Upton, Robert A" uniqKey="Upton R" first="Robert A." last="Upton">Robert A. Upton</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Pharmacy, University of California, 94143, San Francisco, California</mods:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Pharmacy, University of California, 94143, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Thiercelin, Jean Francois" sort="Thiercelin, Jean Francois" uniqKey="Thiercelin J" first="Jean-Francois" last="Thiercelin">Jean-Francois Thiercelin</name>
<affiliation wicri:level="1"><mods:affiliation>Laboratoires d'Études et de Recherches Synthelabo, 58 Rue de la Glacière, 75013, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoires d'Études et de Recherches Synthelabo, 58 Rue de la Glacière, 75013, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guentert, Theodor W" sort="Guentert, Theodor W" uniqKey="Guentert T" first="Theodor W." last="Guentert">Theodor W. Guentert</name>
<affiliation wicri:level="1"><mods:affiliation>School of Pharmacy, University of Basel, Totengaesslein 3, Basel, Switzerland</mods:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Pharmacy, University of Basel, Totengaesslein 3, Basel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wallace, Sylvia M" sort="Wallace, Sylvia M" uniqKey="Wallace S" first="Sylvia M." last="Wallace">Sylvia M. Wallace</name>
<affiliation wicri:level="1"><mods:affiliation>College of Pharmacy, University of Saskatchewan, S7N-OWO, Saskatoon, Saskatchewan, Canada</mods:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>College of Pharmacy, University of Saskatchewan, S7N-OWO, Saskatoon, Saskatchewan</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Powell, J Robert" sort="Powell, J Robert" uniqKey="Powell J" first="J. Robert" last="Powell">J. Robert Powell</name>
<affiliation wicri:level="2"><mods:affiliation>School of Pharmacy, University of North Carolina, 27514, Chapel Hill, North Carolina</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, 27514, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sansom, Lloyd" sort="Sansom, Lloyd" uniqKey="Sansom L" first="Lloyd" last="Sansom">Lloyd Sansom</name>
<affiliation wicri:level="1"><mods:affiliation>School of Pharmacy, South Australian Institute of Technology, North Terrace, Adelaide, South Australia, Australia</mods:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Pharmacy, South Australian Institute of Technology, North Terrace, Adelaide, South Australia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Riegelman, Sidney" sort="Riegelman, Sidney" uniqKey="Riegelman S" first="Sidney" last="Riegelman">Sidney Riegelman</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Pharmacy, University of California, 94143, San Francisco, California</mods:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Pharmacy, University of California, 94143, San Francisco</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E5715019E678DCA7297BE8A6FC0D7FB05F87868B</idno>
<date when="1982" year="1982">1982</date>
<idno type="doi">10.1007/BF01062330</idno>
<idno type="url">https://api.istex.fr/document/E5715019E678DCA7297BE8A6FC0D7FB05F87868B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002B20</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002B20</idno>
<idno type="wicri:Area/Istex/Curation">002B20</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults</title>
<author><name sortKey="Upton, Robert A" sort="Upton, Robert A" uniqKey="Upton R" first="Robert A." last="Upton">Robert A. Upton</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Pharmacy, University of California, 94143, San Francisco, California</mods:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Pharmacy, University of California, 94143, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Thiercelin, Jean Francois" sort="Thiercelin, Jean Francois" uniqKey="Thiercelin J" first="Jean-Francois" last="Thiercelin">Jean-Francois Thiercelin</name>
<affiliation wicri:level="1"><mods:affiliation>Laboratoires d'Études et de Recherches Synthelabo, 58 Rue de la Glacière, 75013, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoires d'Études et de Recherches Synthelabo, 58 Rue de la Glacière, 75013, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guentert, Theodor W" sort="Guentert, Theodor W" uniqKey="Guentert T" first="Theodor W." last="Guentert">Theodor W. Guentert</name>
<affiliation wicri:level="1"><mods:affiliation>School of Pharmacy, University of Basel, Totengaesslein 3, Basel, Switzerland</mods:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Pharmacy, University of Basel, Totengaesslein 3, Basel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wallace, Sylvia M" sort="Wallace, Sylvia M" uniqKey="Wallace S" first="Sylvia M." last="Wallace">Sylvia M. Wallace</name>
<affiliation wicri:level="1"><mods:affiliation>College of Pharmacy, University of Saskatchewan, S7N-OWO, Saskatoon, Saskatchewan, Canada</mods:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>College of Pharmacy, University of Saskatchewan, S7N-OWO, Saskatoon, Saskatchewan</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Powell, J Robert" sort="Powell, J Robert" uniqKey="Powell J" first="J. Robert" last="Powell">J. Robert Powell</name>
<affiliation wicri:level="2"><mods:affiliation>School of Pharmacy, University of North Carolina, 27514, Chapel Hill, North Carolina</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, 27514, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sansom, Lloyd" sort="Sansom, Lloyd" uniqKey="Sansom L" first="Lloyd" last="Sansom">Lloyd Sansom</name>
<affiliation wicri:level="1"><mods:affiliation>School of Pharmacy, South Australian Institute of Technology, North Terrace, Adelaide, South Australia, Australia</mods:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Pharmacy, South Australian Institute of Technology, North Terrace, Adelaide, South Australia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Riegelman, Sidney" sort="Riegelman, Sidney" uniqKey="Riegelman S" first="Sidney" last="Riegelman">Sidney Riegelman</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Pharmacy, University of California, 94143, San Francisco, California</mods:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Pharmacy, University of California, 94143, San Francisco</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Pharmacokinetics and Biopharmaceutics</title>
<title level="j" type="abbrev">Journal of Pharmacokinetics and Biopharmaceutics</title>
<idno type="ISSN">0090-466X</idno>
<idno type="eISSN">1573-8744</idno>
<imprint><publisher>Kluwer Academic Publishers-Plenum Publishers</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1982-04-01">1982-04-01</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="123">123</biblScope>
<biblScope unit="page" to="134">134</biblScope>
</imprint>
<idno type="ISSN">0090-466X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0090-466X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alpha phase</term>
<term>Aminophylline tablets</term>
<term>Bioavailability</term>
<term>Bioavailability studies</term>
<term>Chronological pattern</term>
<term>Clearance</term>
<term>Clin</term>
<term>Covariance analysis</term>
<term>Different occasions</term>
<term>Distribution nose</term>
<term>Dos</term>
<term>Dose variation</term>
<term>Frequent changes</term>
<term>Intraindividual</term>
<term>Intraindividual variability</term>
<term>Intraindividual variation</term>
<term>Intrasubject variability</term>
<term>Intravenous dose</term>
<term>Intravenous infusion</term>
<term>Less variation</term>
<term>Lighter individuals</term>
<term>Metabolic clearance</term>
<term>Oral solution</term>
<term>Pharmacokin</term>
<term>Pharmacokinetic studies</term>
<term>Pharmacokinetics</term>
<term>Plasma clearance</term>
<term>Plasma concentration</term>
<term>Plasma concentration profile</term>
<term>Plasma curve</term>
<term>Plasma profile peak</term>
<term>Preliminary studies</term>
<term>Preliminary study</term>
<term>Present study</term>
<term>Prime source</term>
<term>Regression analysis</term>
<term>Renal clearance</term>
<term>Sampling schedule</term>
<term>Second sample</term>
<term>Separate doses</term>
<term>Separate occasions</term>
<term>Single doses</term>
<term>Terminal phase</term>
<term>Theophylline</term>
<term>Theophylline kinetics</term>
<term>Theophylline metabolism</term>
<term>Theophylline pharmacokinetics</term>
<term>Total clearance</term>
<term>Variability</term>
<term>Varian instrument</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Alpha phase</term>
<term>Aminophylline tablets</term>
<term>Bioavailability</term>
<term>Bioavailability studies</term>
<term>Chronological pattern</term>
<term>Clearance</term>
<term>Clin</term>
<term>Covariance analysis</term>
<term>Different occasions</term>
<term>Distribution nose</term>
<term>Dos</term>
<term>Dose variation</term>
<term>Frequent changes</term>
<term>Intraindividual</term>
<term>Intraindividual variability</term>
<term>Intraindividual variation</term>
<term>Intrasubject variability</term>
<term>Intravenous dose</term>
<term>Intravenous infusion</term>
<term>Less variation</term>
<term>Lighter individuals</term>
<term>Metabolic clearance</term>
<term>Oral solution</term>
<term>Pharmacokin</term>
<term>Pharmacokinetic studies</term>
<term>Pharmacokinetics</term>
<term>Plasma clearance</term>
<term>Plasma concentration</term>
<term>Plasma concentration profile</term>
<term>Plasma curve</term>
<term>Plasma profile peak</term>
<term>Preliminary studies</term>
<term>Preliminary study</term>
<term>Present study</term>
<term>Prime source</term>
<term>Regression analysis</term>
<term>Renal clearance</term>
<term>Sampling schedule</term>
<term>Second sample</term>
<term>Separate doses</term>
<term>Separate occasions</term>
<term>Single doses</term>
<term>Terminal phase</term>
<term>Theophylline</term>
<term>Theophylline kinetics</term>
<term>Theophylline metabolism</term>
<term>Theophylline pharmacokinetics</term>
<term>Total clearance</term>
<term>Variability</term>
<term>Varian instrument</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: After administering a single 300 mg dose of theophylline in oral solution to 12 healthy adults, the dose-normalized area under the plasma concentration-time curve was 97.2±20.1 % (mean±SD) of that after giving a 500 mg dose and statistically indistinguishable. Similarly, these areas multiplied by the individual's terminal disposition rate constant (β) were statistically indistinguishable between 300 and 500mg doses (99.1±10.3%), giving no evidence of dose-dependence for theophylline kinetics at the levels below 15 μg/ml observed in these individuals. After an intravenous dose, a shortlived distribution phase (t1/2α) is sometimes seen. An a phase, however, is hardly discernible in over 250 profiles arising from oral doses administered during five single dose bioavailability studies. Almost all such profiles appear to follow single-compartment model predictions. With precautions to avoid a potential a phase, a terminal log-linear slope can be fitted by least squares analysis with a relative standard error in the slope determination almost always less than 6%. Covariance analysis confirms statistically that 39 of the 60 participating individuals varied in their β on the different occasions each was required to take a dose during the course of a crossover bioavailability trial. In one study, even though each individual was observed on only two occasions, 9 out of 12 showed statistically identifiable variation in β. Fluctuations in β of 60% can be seen. Changes of 30% or greater are common and can occur within 3 or 4 days. Thus real, large, and potentially frequent changes in β of theophylline have been identified in a majority of normal subjects. These changes do not appear to be confined to either sex, to smokers or nonsmokers, or to heavier or lighter individuals. No chronological pattern has, as yet, been recognized in the intraindividual variability in β.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Istex/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B20 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002B20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:E5715019E678DCA7297BE8A6FC0D7FB05F87868B
   |texte=   Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri